![PDF) Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-up PDF) Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-up](https://i1.rgstatic.net/publication/276456184_Advanced_hepatocellular_carcinoma_and_sorafenib_Diagnosis_indications_clinical_and_radiological_follow-up/links/5bb3491592851ca9ed33fe9d/largepreview.png)
PDF) Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-up
![Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review - ScienceDirect Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1558767316300106-gr1.jpg)
Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review - ScienceDirect
Aan de Minister van Volksgezondheid, Welzijn en Sport Postbus 20350 2500 EJ 'S-GRAVENHAGE 3 augustus 2006 Farmatec/P-2705783 2
![PDF) SP94-Targeted Nanoparticles Enhance the Efficacy of Sorafenib and Improve Liver Cancer Cell Discrimination PDF) SP94-Targeted Nanoparticles Enhance the Efficacy of Sorafenib and Improve Liver Cancer Cell Discrimination](https://www.researchgate.net/profile/Cameron-Evans-3/publication/348093444/figure/fig2/AS:1101118306287617@1639538470547/Cell-viability-assay-of-A-Hep3B-treated-with-sorafenib-control-sorafenib-NPs_Q320.jpg)
PDF) SP94-Targeted Nanoparticles Enhance the Efficacy of Sorafenib and Improve Liver Cancer Cell Discrimination
![Identification of Functional MKK3/6 and MEK1/2 Homologs from Echinococcus granulosus and Investigation of Protoscolecidal Activity of Mitogen-Activated Protein Kinase Signaling Pathway Inhibitors <i>In Vitro</i> and <i>In Vivo</i>. - Abstract - Europe PMC Identification of Functional MKK3/6 and MEK1/2 Homologs from Echinococcus granulosus and Investigation of Protoscolecidal Activity of Mitogen-Activated Protein Kinase Signaling Pathway Inhibitors <i>In Vitro</i> and <i>In Vivo</i>. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6325220/bin/AAC.01043-18-f0005.jpg)
Identification of Functional MKK3/6 and MEK1/2 Homologs from Echinococcus granulosus and Investigation of Protoscolecidal Activity of Mitogen-Activated Protein Kinase Signaling Pathway Inhibitors <i>In Vitro</i> and <i>In Vivo</i>. - Abstract - Europe PMC
Nexavar® (sorafenib) w leczeniu postępującego, miejscowo zaawansowanego lub z przerzutami, zróżnicowanego raka tarczycy (br
![PDF) Phase II Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Sorafenib in Japanese Patients with Advanced Renal Cell Carcinoma PDF) Phase II Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Sorafenib in Japanese Patients with Advanced Renal Cell Carcinoma](https://i1.rgstatic.net/publication/5895054_Phase_II_Study_to_Investigate_the_Efficacy_Safety_and_Pharmacokinetics_of_Sorafenib_in_Japanese_Patients_with_Advanced_Renal_Cell_Carcinoma/links/53d5a0a20cf228d363ea0d95/largepreview.png)